Sputnik V COVID-19 Vaccine Secure In India Mid-Degree Trial: Dr Reddy’s
Dr Reddy’s Laboratories Ltd stated on Monday an unbiased board discovered Russia’s Sputnik V COVID-19 vaccine to be protected in its mid-stage trial in India, and really helpful progressing to late-stage trials.
The corporate has submitted the mid-stage trial protection information to India’s drug regulator for assessment and approval to proceed late-stage trials, Dr.Reddy’s stated in a regulatory submitting.
(Except for for the headline, this tale has no longer been edited by way of TTN body of workers and is revealed from a syndicated feed.)